Stem cell therapy for severe lung disease in premature babies
Treatments studied
Part of Genetic & congenital, Lungs & breathing, Women’s health & pregnancy clinical trials.
This trial tests whether umbilical cord stem cells can help premature babies with severe bronchopulmonary dysplasia (a chronic lung disease) who still need a breathing tube after standard hormone treatment. The goal is to see if it is safe and improves their lung condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby was born between 23 and 29 weeks of pregnancy.
- Your baby weighed between 500 and 1500 grams at birth.
- Your baby still needs a breathing tube at 36 weeks corrected age despite hormone therapy (DART).
- Your baby has severe bronchopulmonary dysplasia (BPD) and was given surfactant early on.
- You agree to let your baby participate in this research study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if intravenous immunoglobulin (IVIG) can help prevent or treat bronchopulmonary dysplasia (BPD), a lung condition in premature babies. It is for very preterm infants born between 25 and 29 weeks who show early signs of BPD and are enrolled in the first day of life.
This trial tests whether giving intravenous immunoglobulin (IVIG) early after birth can help prevent or treat a serious lung condition called bronchopulmonary dysplasia (BPD) in babies born at 28 weeks or earlier. It may help reduce the need for breathing support and oxygen.
This early trial tests if airway basal stem cells can help children with a serious lung condition called bronchiolitis obliterans. It aims to improve lung function and reduce the need for oxygen or breathing support.
This study tests whether a medicine called dexamethasone (a steroid) can help prevent a serious lung problem in very premature babies. It is for babies who still need a breathing machine after two weeks of life.
This trial tests a new treatment using stem cells from umbilical cords to help people with scleroderma-related lung disease. It aims to see if the treatment can slow down or improve lung scarring and breathing problems.
This Phase 1 trial tests whether giving stem cells into a breathing tube is safe and may help prevent bronchopulmonary dysplasia (BPD), a serious lung condition in very premature infants. It focuses on babies soon after birth who already need breathing support and are at risk.
Hear when a new BPD - Bronchopulmonary Dysplasia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.